Foresite Capital Opportunity Management V »

Gemini Therapeutics shares owned by Foresite Capital Opportunity Management V

Quarter-by-quarter ownership of Gemini Therapeutics shares owned by Foresite Capital Opportunity Management V from 13F filings

Historical chart of Foresite Capital Opportunity Management V investment in Gemini Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gemini Therapeutics held by Foresite Capital Opportunity Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gemini Therapeutics by Foresite Capital Opportunity Management V

Quarter filed Position value Share count Share price at filing
2022-09-30 $4.0M 2.4M 1.64
2022-06-30 $4.1M 2.4M 1.69
2022-03-31 $3.4M 2.4M 1.39
2021-12-31 $7.1M 2.4M 2.91

More positions owned by Foresite Capital Opportunity Management V

Pardes Biosciences
Theseus Pharmaceuticals
Gemini Therapeutics
Compass Therapeutics (CMPX)
Kinnate Biopharma (KNTE)
Adicet Bio (ACET)
Quantum-Si Incorporated Com Cl A (QSI)
Hims & Hers Health Com Cl A (HIMS)
Enanta Pharmaceuticals (ENTA)

View all positions for Foresite Capital Opportunity Management V